Gilead awarded European Commission marketing authorisation for Truvada for reducing risk of sexually...
Gilead awarded European Commission marketing authorisation for Truvada for reducing risk of sexually acquired HIV-1
About this item
Full title
Gilead awarded European Commission marketing authorisation for Truvada for reducing risk of sexually acquired HIV-1
Publisher
London: Normans Media Ltd
Journal title
M2 Pharma, 2016
Language
English
Formats
Publication information
Publisher
London: Normans Media Ltd
Subjects
More information
Scope and Contents
Contents
M2PHARMA-August 23, 2016-Gilead awarded European Commission marketing authorisation for Truvada for reducing risk of sexually acquired HIV-1 (C)2016 M2 COMMUNICATIONS http://www.m2.com Biopharmaceutical company Gilead Sciences (Nasdaq:GILD) reported on Monday the receipt of marketing authorisation fro...
Alternative Titles
Full title
Gilead awarded European Commission marketing authorisation for Truvada for reducing risk of sexually acquired HIV-1
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1813143420
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1813143420
How to access this item
Log in as a Library member
